ANKURDRUGS

Ankur Drugs And Pharma Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on September 01, 2010 have recommended at dividend @ Rs.2.25 per share (@ 22.5% per share) for equity share of Rs.10/- each, subject to approval to the shareholders.

Ankur Drugs And Pharma Limited has informed the Exchange that the Board of Directors have resolved by a resolution passed through circulation to make an application with ROC, Maharashtra, Mumbai for extension for convening AGM by 3 months U/s 166(1) of the Companies Act, 1956. The decision of ROC is still pending.

Ankur Drugs And Pharma Limited has informed the Exchange that the company has passed the following resolutions at the meeting of its Board of Directors held on April 01, 2010: The board decided to invest in the entire paid up share capital of TVC Life Sciences Limited in order to make it its wholly owned subsidiary. Since this transaction is within the limits of section 372A no shareholders permission would be required. Currently TVC Sky Shop Limited hold 99.94% shares in share capital of TVC Life Sciences Limited.

Ankur Drugs And Pharma Limited had informed the Exchange that "The Company in its meeting of the Board Directors held on November 13, 2009 at its Registered office has passed the resolution for the following; Issued and allotted 326119 Equity Share of Rs.10/- each on conversion of 1000 FCCB of UDS 1000.00 each at the conversion price of Rs.165/- inclusive of the accretion yield of 5% p.a., i.e. 48048 equity shares of Rs.10 each, from the date of issue till the receipt of notice of conversion, to Merrill Lynch Capital Markets Espana S. A. SV, Edificio Torre Picasso, Plaza Pablo Ruiz Picasso s/n

Ankur Drugs And Pharma Limited has informed the Exchange that "The Company in its meeting of the Board Directors held on November 13, 2009 at its Registered office has passed the resolution for the following; Issued and allotted 326119 Equity Share of Rs.10/- each on conversion of 1000 FCCB of UDS 1000.00 each at the conversion price of Rs.165/- inclusive of the accretion yield of 5% p.a., i.e. 48048 equity shares of Rs.10 each, from the date of issue till the receipt of notice of conversion, to Merrill Lynch Capital Markets Espana S. A. SV, Edificio Torre Picasso, Plaza Pablo Ruiz Picasso s/n

Ankur Drugs And Pharma Limited has informed the Exchange that the Board of Directors in their meeting held on October 28, 2009 has passed the resolution for the following: Constitution of a Finance Committee for arrangement with banks and financial institutions for borrowing of money.

Ankur Drugs And Pharma Limited has informed the Exchange that following resolutions were passed by the members at the Annual General Meeting of the Company held on September 29, 2009 : Ordinary business : 1) The Audited Balance Sheet as at March 31, 2009 and the Profit and Loss Account for the year ended on that date and the Report of the Directors and Auditors thereon were approved and adopted. 2) Declared a dividend of 22.5% (Rs. 2.25 per share) on equity shares for the Financial Year ended March 31, 2009. 3) Mr. Dileep Shinde, who retired by rotation was re-appointed as a Director of the Co

Ankur Drugs And Pharma Limited has informed the Exchange that "Mr. Lalit Agarwal, Director of the company has resigned from the Board of Directors vide letter dated August 24, 2009 and the letter of resignation was placed on the Board Meeting held on September 1, 2009 where the same was accepted with immediate effect."

Ankur Drugs And Pharma Limited has informed the Exchange that dividend to be paid within 30 days of declaring the dividend in the Annual General Meeting held on September 29, 2009.

Ankur Drugs And Pharma Limited has informed the Exchange that the Board of Directors in its meeting held on September 01, 2009 has taken the following decisions :- (1) The Annual General Meeting of the Company will be held on September 29, 2009. (2) The Register of Members and the Transfer Books of the Company will be closed from September 25, 2009 to September 29, 2009 (both days inclusive) for the purpose of Dividend and AGM. (3) The Board has approved the Audited Annual Accounts, Director's Report, Auditor's Report and the Corporate Governance Report for the financial year ending March 31,

Ankur Drugs And Pharma Limited has submitted to the Exchange a copy of Minutes of the Postal Ballot conducted by the Company on July 25, 2009. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/ankur_MPB_11082009.zip target=NEW> For more details click here.</a>

Ankur Drugs And Pharma Limited has informed the Exchange that the Company had conducted the Postal Ballot for the following Resolution, and that the said Resolution, and that the said Resolution have been passed with the requisite majority, as per the provisions of the Section 192A of the Companies Act, 1956 read with Companies (Passing of Resolutions by Postal Ballot) Rules, 2001. The result of the Postal Ballot as declared on July 25, 2009 shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Ann

Ankur Drugs And Pharma Limited has informed the Exchange that Notice pursuant to Section 192A of the Companies Act,1956 read with the Companies (Passing of Resolution by Postal Ballot) Rules, 2001 and any amendments thereto, is hereby given that the draft resolution mentioned herein below is proposed to be passed through the process of Pastol Ballot: 1.Ordinary Resolution under Section 293(1)(a) of Companies Act,1956 to create and/or change and/or hypothecate all or any of movable and immovable properties and assets of theCompany. A copy of Notice of the Postal Ballot shall be available on the

Ankur Drugs And Pharma Limited has informed the Exchange that the proposal to create and/or charge and/or hypothecate all or any of the moveable and immovable properties, assets of the Company in pursuance of Section 293(1)(a) of the Companies Act, 1956 which was placed for consideration of the Board of Directors of the Company at its meeting held on June 15, 2009 was approved thereat. The Board has also approved seeking the consent of the Members to the said proposal through the process of Postal Ballot under Section 192A of the Companies Act, 1956. The Board has also approved the Calendar of

Ankur Drugs And Pharma Limited has informed the Exchange that the Board of Directors in its meeting held on May 12, 2009 resolved: (1) To allot 4,00,000 fully paid equity shares of Rs. 10 each to Mr. Purnandu Jain pursuant to conversion of its 4,00,000 share warrants (each warrant convertible into 1 equity share of Rs. 10 /- each) held by Mr. Purnandu Jain at an agreed price of Rs.175/- per share warrant, as per the terms of issue of share warrants on a preferential basis. (2) To forfeit the amount received on remaining 17,24,400 share warrants on account of non-exercise of the right of conver

Ankur Drugs And Pharma Limited has informed the Exchange that Mr. S. C. Rane, Manager - Legal and Company Secretary, has been appointed as the Compliance officer of the Company w.e.f. August 27, 2008 in place of Mr. James Pinto.

Ankur Drugs And Pharma Limited has informed the Exchange regarding the resolutions passed by the members at the Annual General Meeting of the Company held on September 27, 2008. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/ankurdrugs_OUTAGM_01102008.zip target=NEW> For more details click here.</a>

Ankur Drugs And Pharma Limited has informed the Exchange that the Board of Directors in its meeting held on August 27, 2008 has taken the following decision :- (1) The Annual General Meeting of the Company will be held on September 27, 2008. (2) The Board has approved the Audited Annual Accounts for the year 2007-08. (3) The Directors have recommended a dividend @ Rs.2.25 per share (@ 22.5% per share) for equity share of Rs.10/- each, subject to the approval of the shareholders. (4)The register of Members and Transfer Books of the Company will be closed from September 23, 2008 to September 27,

Ankur Drugs And Pharma Limited has informed the Exchange that the Company in its meeting of the Board of Directors held on July 26, 2008, has taken the following decision: 1) Acceptance of resignation of Mrs. Manisha Jhaveri as director of the Company.

Ankur Drugs And Pharma Limited has submitted to the Exchange a copy of the Minutes of the Meeting of Board of Directors of the Company held on April 23, 2008. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Ankur_MIn_Meet_24042008.zip target=NEW> For more details click here.</a>

Ankur Drugs And Pharma Limited has submitted to the Exchange a copy of the Minutes of the Meeting of Board of Directors of the Company held on April 15, 2008.The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Ankur_Minuteofmeeting_23042008.zip target=NEW> For more details click here.</a>

Ankur Drugs And Pharma Limited has informed the Exchange that : " The registered office of the company has shifted to new address the details of which is given below, jurisdiction under Registrar of companies being the same". New Address:- 20th Floor, Lotus Business Park, Off Andheri Link Road, Andheri West, Mumbai 400 053. Tel: 40682300 (Hunting lines) Fax: 40682333. Old Address:- C-306, Crystal Plaza, Andheri Link Road, Andheri West , Mumbai 400 053.

Ankur Drugs And Pharma Limited had informed the Exchange that the Books of members will be closed between December 21, 2007 to December 31, 2007 (both days inclusive) for the purpose of Dividend and Annual General Meeting. The Company has now informed the Exchange that the date mentioned for book closure was incorrect. Instead of December 21, 2007, the Books of members will be closed between December 24, 2007 to December 31, 2007 (both days inclusive) for the purpose of Dividend and Annual General Meeting.

Ankur Drugs And Pharma Limited has informed the Exchange that the Board of Directors of the Company has in its Board Meeting held on November 30, 2007, recommended a dividend of 20% for financial year ended 2006-2007.

Ankur Drugs And Pharma Limited has informed the Exchange that the Books of members will be closed between December 21, 2007 to December 31, 2007 (both days inclusive) for the purpose of Dividend and Annual General Meeting.

Ankur Drugs And Pharma Limited has informed the Exchange that "As per the Hon'ble High Court of Judicature at Bombay by its Order dated 31st August, 2007, We have passed the resolution for Amalgamation of Ankur Drugs and Pharma Limited with Vaibhav Healthcare Private Limited with the approval of Equity Shareholders by taking a poll at the Court convened meeting of the company held on 08th October, 2007 at Garden Court, Veera Desai road, Mumbai-400 053. The meeting of the Equity Shareholders was attended by 44 Equity Shareholders of the Company; 23 shareholders present in person and 21 sharehol

Ankur Drugs And Pharma Limited has informed the Exchange that by an Order dated August 31, 2007 the Hon'ble High Court of Judicature at Bombay has directed that a meeting of the Equity Shareholders of Ankur Drugs and Pharma Limited, the Applicant, be convened on October 08, 2007 for the purpose of considering and if thought fit, approving with or without modification, the arrangement embodied in the Scheme of Amalgamation of Vaibhav Healthcare Private Limited (the "Transferor Company") with Ankur Drugs and Pharma Limited (the "Transferee Company/Applicant") and their respective shareholders an

Ankur Drugs And Pharma Limited has informed the Exchange that the company has allotted Equity Share Warrants & Equity shares in the Meeting of Board of Directors held on September 05, 2007. (1)The Company has allotted 21,24,400 Equity Share Warrants to Promoters, Friends, Relatives, Employees & business associates. (2) The Company has also allotted 20,43,000 Equity Shares of the Company on Preferential allotment basis. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate An

Ankur Drugs And Pharma Limited has informed the Exchange that : "The Company has allotted 1,02,817 Equity Shares of Rs.10/- each on 4th June , 2007 to Grants Investments Limited, Mauritius on account of reset price and accredition @ 5% pa on conversion of 4,000 Foreign Currency Convertible Bonds of USD 1000 each".

Ankur Drugs And Pharma Limited has informed the Exchange that the Company has signed "Technology Agreements" with Labtec GmbH of Germany & Applied Pharma Research, S.A. Of Switzerland for an exclusive "Intellectual property rights" for a novel technology. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Ankur_PR_TechAgreements.zip target=NEW> For more details click here.</a>